SCARSI, Mirko
 Distribuzione geografica
Continente #
EU - Europa 2.462
NA - Nord America 2.056
AS - Asia 867
SA - Sud America 125
Continente sconosciuto - Info sul continente non disponibili 74
AF - Africa 30
OC - Oceania 2
Totale 5.616
Nazione #
US - Stati Uniti d'America 2.002
IT - Italia 1.660
CN - Cina 307
SG - Singapore 306
DE - Germania 207
UA - Ucraina 163
BR - Brasile 108
FR - Francia 107
HK - Hong Kong 81
FI - Finlandia 80
GB - Regno Unito 72
RU - Federazione Russa 48
VN - Vietnam 48
TR - Turchia 34
CA - Canada 33
IN - India 31
IE - Irlanda 26
SE - Svezia 20
NL - Olanda 18
BD - Bangladesh 15
ZA - Sudafrica 13
ES - Italia 12
MX - Messico 11
IQ - Iraq 10
JP - Giappone 9
PL - Polonia 8
CH - Svizzera 7
AR - Argentina 6
AT - Austria 6
NG - Nigeria 6
CO - Colombia 4
EU - Europa 4
NP - Nepal 4
RO - Romania 4
CZ - Repubblica Ceca 3
EC - Ecuador 3
ID - Indonesia 3
JM - Giamaica 3
JO - Giordania 3
MA - Marocco 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
IL - Israele 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.547
Città #
Ashburn 227
Singapore 177
Fairfield 128
Milan 120
Jacksonville 119
San Jose 119
Rome 117
Woodbridge 115
Ann Arbor 105
Beijing 104
Hong Kong 81
Houston 71
Chandler 61
Wilmington 58
New York 54
The Dalles 54
Seattle 53
Helsinki 52
Cambridge 50
Princeton 50
Los Angeles 41
Turin 41
Nanjing 40
Council Bluffs 37
Bologna 35
Dallas 34
Munich 34
Brescia 28
Istanbul 26
Dublin 25
Lauterbourg 25
Florence 23
Columbus 20
Des Moines 17
Ho Chi Minh City 17
Nanchang 17
Orem 17
Moscow 16
São Paulo 15
Mumbai 14
Verona 14
Buffalo 13
Dearborn 13
Genoa 13
Padova 13
Modena 12
Torino 12
Montreal 11
Naples 11
Santa Clara 11
Trieste 11
Sassari 10
Venice 10
Changsha 9
Hanoi 9
Hebei 9
Johannesburg 9
San Francisco 9
Shanghai 9
Shenyang 9
Brooklyn 8
Chicago 8
Phoenix 8
Reggio Nell'emilia 8
Tianjin 8
Tokyo 8
Atlanta 7
Bari 7
Boardman 7
Jinan 7
Palermo 7
Redondo Beach 7
Trento 7
Turku 7
Chennai 6
Denver 6
Genova 6
Jiaxing 6
London 6
Manchester 6
Messina 6
Nürnberg 6
Perugia 6
Poplar 6
San Diego 6
Stockholm 6
Toronto 6
Warsaw 6
Abuja 5
Ankara 5
Bergamo 5
Catania 5
Duino-Aurisina 5
Ferrara 5
Frankfurt am Main 5
Frosinone 5
Hangzhou 5
Lanzhou 5
Vancouver 5
Vienna 5
Totale 2.902
Nome #
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.872
Microvascular Density and Circulating Endothelial Progenitor Cells Before and After Treatment with Incretin Mimetics in Diabetic Patients 211
Relationship Between Different Subpopulations of Circulating CD4+ T-lymphocytes and Microvascular Structural Alterations in Humans 194
Prophylaxis and therapy of HBV infection in 20 patients treated with disease modifying antirheumatic drugs or with biological agents for rheumatic diseases. 178
Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans 173
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 166
Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis. 162
LA PREDITTIVITA DEGLI ANTICORPI ANTI-RO/SSA-P200 NEL BLOCCO CARDIACO CONGENITO 160
RELATIONSHIP BETWEEN MICROVASCULAR T REGULATORY LYMPHOCYTES AND CIRCULATING LYMPHOCYTES 160
Intravenous cyclophosphamide for interstitial lung disease associated to systemic sclerosis: results with an 18-month long protocol including a maintenance phase 157
Impact of in utero environment on the offspring of lupus patients 154
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abatacept 147
WINTER LUPUS FLARES ARE ASSOCIATED WITH LOWER VITAMIN D LEVELS IN A RETROSPECTIVE LONGITUDINAL STUDY OF ITALIAN PATIENTS 146
Type I interferons in systemic autoimmunity. 139
DECREASED TITER OF ANTI-CCP ANTIBODIES AND RHEUMATOID FACTOR AND REDUCTION OF POSTSWITCH MEMORY B CELLS AFTER ABATACEPT TREATMENT FOR RHEUMATOID ARTHRITIS 139
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis 139
THE EFFECTS ON T-CELL IMMUNE PHENOTYPE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TREATED WITH TWO DIFFERENT REGIMENS OF VITAMIN D SUPPLEMENTATION 138
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 136
REDUCTION OF PERIPHERAL BLOOD G-IFN AND IL-17 PRODUCING T CELLS AFTER THERAPY WITH ABATACEPT FOR RHEUMATOID ARTHRITIS 124
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al 121
Pregnancy in systemic sclerosis: a prospective study 119
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease 117
REDUCTION OF T-CELL CLONAL EXPANSION IN RHEUMATOID ARTHRITIS PATIENTS AFTER 12 MONTHS OF ABATACEPT TREATMENT. 102
Intravenous immunoglobulin in pregnancy: a chance for patients with an autoimmune disease. 99
LOW NUMBERS OF CIRCULATING CD28 NEGATIVE T CELLS MAY BE A PREDICTIVE FACTOR OF A GOOD CLINICAL RESPONSE TO ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS 97
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome 93
LA RIDUZIONE DEL NUMERO ASSOLUTO DELLE CELLULE T CD8+CD28- CIRCOLANTI ENTRO 6 MESI DI TERAPIA CON ABATACEPT COME FATTORE PREDDITIVO DI BUONA RISPOSTA CLINICA A 1 ANNO 87
Treatment with COLchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial 86
Totale 5.616
Categoria #
all - tutte 20.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022402 0 0 0 40 20 63 40 44 34 52 48 61
2022/2023397 46 10 16 24 38 68 13 37 68 16 35 26
2023/2024344 21 9 25 36 21 58 16 23 55 7 29 44
2024/2025726 45 21 9 79 88 100 60 53 58 30 115 68
2025/20261.179 134 140 77 178 166 118 151 41 50 65 36 23
2026/2027297 38 48 89 122 0 0 0 0 0 0 0 0
Totale 5.616